X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fiercepharma.com/marketing/ani-focuses-data-insights-ramp-its-arthritis-and-ms-flare-therapy
https://in.reuters.com/article/us-usa-mallinckrodt-lawsuit/us-sues-mallinckrodt-accuses-drugmaker-of-defrauding-medicaid-idINKBN20Q2FV
https://www.prnewswire.com/news-releases/data-on-acthar-gel-repository-corticotropin-injection-therapy-in-symptomatic-sarcoidosis-published-in-therapeutic-advances-in-respiratory-disease-300965058.html
https://www.reuters.com/article/us-mallinckrodt-lawsuit/mallinckrodt-receives-sec-subpoena-over-acthar-gel-lawsuit-idUSKBN1XF2QR?feedType=RSS&feedName=healthNews
https://www.fiercepharma.com/manufacturing/mallinckrodt-unloads-its-cdmo-for-250m-as-liabilities-mushroom
https://www.fiercepharma.com/pharma/mallinckrodt-investors-stream-for-exits-as-opioid-tied-bankruptcy-talk-mounts
http://www.pharmatimes.com/news/mallinckrodt_halts_mid-stage_acthar_trial_citing_pneumonia_risk_1294889
https://edition.cnn.com/2018/06/29/health/acthar-mallinckrodt-medicare-claims-doctor-payments/index.html
http://www.prnewswire.com/news-releases/mallinckrodt-enrolls-first-patient-in-phase-2b-trial-of-hp-acthar-gel-repository-corticotropin-injection-for-amyotrophic-lateral-sclerosis-als-300474152.html
http://www.reuters.com/article/us-mallinckrodt-generics-exclusive-idUSKBN18Q2F6
http://www.reuters.com/article/us-hedgefunds-salt-chanos-idUSKCN18E2WP?feedType=RSS&feedName=healthNews
http://www.lachmanconsultants.com/2017/01/fda-declares-drug-product-removed-for-safety-reasons/
http://www.bloomberg.com/news/articles/2015-12-23/shkreli-wasn-t-the-first-to-hike-drug-prices-and-he-won-t-be-the-last
http://www.bloomberg.com/news/articles/2015-11-09/mallinckrodt-slumps-on-scrutiny-from-valeant-foe-citron-research
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/01/report-card-fda-gets-a-solid-b-on-timely-responding-to-section-505w-discontinuation-citizen-petition.html
Market Place
Share 
